Author:
Khanna Dinesh,Merkel Peter A.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Altman RD, Medsger TA Jr, Bloch DA, Michel BA: Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991, 34:403–413.
2. Merkel PA, Clements PJ, Reveille JD, et al.: Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 2003, 30:1630–1647.
3. White B, Bauer EA, Goldsmith LA, et al.: Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum 1995, 38:351–360.
4. Baroni SS, Santillo M, Bevilacqua F, et al.: Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006, 354:2667–2676.
5. Furst DE, Khanna D, Mattucci-Cerinic M, et al.: Scleroderma—developing measures of response. J Rheumatol 2005, 32:2477–2480.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献